Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
In the latest session, Beam Therapeutics Inc (NASDAQ: BEAM) closed at $25.38 up 2.75% from its previous closing price of $24.70. In other words, the price has increased by $2.75 from its previous closing price. On the day, 0.89 million shares were traded. BEAM stock price reached its highest trading level at $26.14 during the session, while it also had its lowest trading level at $24.6647.
Ratios:
For a deeper understanding of Beam Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.69 and its Current Ratio is at 5.69. In the meantime, Its Debt-to-Equity ratio is 0.20 whereas as Long-Term Debt/Eq ratio is at 0.19.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Leerink Partners on November 06, 2024, Upgraded its rating to Outperform and sets its target price to $39 from $27 previously.
On July 23, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $80.H.C. Wainwright initiated its Buy rating on July 23, 2024, with a $80 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 31 ’24 when BETHANY J. CAVANAGH bought 9,500 shares for $25.27 per share.
CHRISTINE BELLON bought 4,167 shares of BEAM for $105,300 on Dec 31 ’24. On Nov 06 ’24, another insider, Ciaramella Giuseppe, who serves as the President of the company, sold 51,110 shares for $26.36 each. As a result, the insider received 1,347,050 and left with 109,150 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BEAM now has a Market Capitalization of 2101606016 and an Enterprise Value of 1256359552. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.18 while its Price-to-Book (P/B) ratio in mrq is 2.65. Its current Enterprise Value per Revenue stands at 3.593 whereas that against EBITDA is -7.812.
Stock Price History:
Over the past 52 weeks, BEAM has reached a high of $49.50, while it has fallen to a 52-week low of $20.84. The 50-Day Moving Average of the stock is -2.30%, while the 200-Day Moving Average is calculated to be -0.89%.
Shares Statistics:
For the past three months, BEAM has traded an average of 1.12M shares per day and 1061470 over the past ten days. A total of 82.56M shares are outstanding, with a floating share count of 72.66M. Insiders hold about 12.25% of the company’s shares, while institutions hold 81.91% stake in the company. Shares short for BEAM as of 1734048000 were 10057155 with a Short Ratio of 8.97, compared to 1731628800 on 11966576. Therefore, it implies a Short% of Shares Outstanding of 10057155 and a Short% of Float of 15.879999999999999.
